MOMMY:
Another day of chemo. I'm happy to say Luis did pretty well with the treatment. The worst part was the insertion and removal of the port needle. Even that wasn't as bad as expected thanks to the help of our new friend Emla, a numbing cream applied an hour before our appointment.
 |
| A 5-hr visit for bloodwork and chemotherapy |
The oncologist gave us some reassuring news: Luis is right on track with his chemo. His sore tummies, occasional vomiting, endless appetite, and explosive outbursts are all 'normal' and expected with his treatment.
Next Friday, June 16 will be Day 29 of his chemo. That will mark the end of the Induction phase. We expect Luis to receive more chemo through his port, another chemo drug, methotrexate, in the spine, and potentially another bone marrow sample. I'm waiting for an appointment to be scheduled for a CT scan next week also. That should give us more confirmation that the treatment is working.
The best news the doctor gave us is that we should be able to return to Windsor after chemo on Friday. The week between Day 29 and Day 36 will be a drug-free vacation at our house. I can't wait to settle into a routine with the kids. After nearly a month of being in London, I think we all miss our own beds and food. On the following Friday, Day 36, we have to return to London for the start of the next phase of treatment, Consolidation. The doctor didn't confirm the frequency of our upcoming visits, although weekly visits may be required.
The clinical trial
A big decision Daddy and I have to make is whether or not to allow Luis to participate in a clinical trial. If he participates, he would receive one of two streams of treatment.
- Standard treatment: This is the treatment he would receive even if he didn't participate in the trial.
- Intensified Methotrexate, Nelarabine and Augmented BFM Therapy: Patients with T-Cell Non-Hodgekins Lymphoma (T-NHL) like Luis are
usually treated with the same type of chemotherapy treatment used for
the related T-cell acute lymphoblastic leukemia (T-ALL). The second possible treatment stream includes the same medications as the standard treatment but at higher levels and includes an additional drug, nelarabine. This treatment is currently used for T-ALL patients.
If we agree to participate in the trial, we will randomly be assigned to one of the treatment streams, either 1 or 2. It's a big decision.
PROS:
Luis' current treatment is possible through
years of other kids on clinical trials. Information gained from the
study can be used to help other patients in the future. We have an
opportunity to pay it forward.
Luis would be closely monitored and the
doctors may choose to take him out of the study in order to make the
best decisions for him based on his response to the treatment.
We can pull out of the trial at any time with no effect on his future care.
CONS:
We don't know if we would be assigned the standard treatment or the intensified treatment.
The unknown: the 2nd treatment could be
better, worse or the same as the standard treatment at treating the
cancer. With the 2nd treatment, there could also be side effects
additional to the standard treatment.
More tests (and medicine if we get the 2nd
treatment stream) than if we didn't participate in the trial. His
medical information would be collected for 10 years after entering the
study.
This is just a snap shot of what we have to consider. Based on this info, do you think the trial is a good idea? You can give your opinion using the polling button on the right side bar near the top. Also, if anyone knows anyone who has been in a this trial (COG AALL0434) or a similar one, I'd love to get your comments.